Skip to main content
. 2022 May 19;17(5):e0268521. doi: 10.1371/journal.pone.0268521

Table 2. Factors associated with prevalent anal HPV 16 infection.

Independent variables Prevalent Anal HPV 16 in category Unadjusted analysis Adjusted model
n (%) OR 95%CI OR 95%CI
Age at baseline in years 1.0 1.0–1.1 1.0 0.9–1.1
    19–39 6 (15.4%)
    40–49 10 (15.4%)
    50–69 7 (15.2%)
Smoking
    Never 10 (9.8%) Ref. Ref.
    Past 4 (18.2%) 2.0 0.6–7.2 1.9 0.4–10.4
    Current 9 (34.6%) 4.9 1.7–13.8 6.0 1.5–23.9
CD4 cell count at baseline (chart review)
    >200 (cells/μL of blood) 19 (13.5%) Ref. Ref.
    ≤200 (cells/μL of blood) 4 (44.4%) 5.1 1.3–20.8 0.9 0.1–6.4
Nadir CD4 cell count (chart review)
    >200 (cells/μL of blood) 5 (6.1%) Ref. Ref.
    ≤200 (cells/μL of blood) 18 (26.5%) 5.5 1.9–15.9 8.4 2.0–34.3
HIV viral load at baseline (chart review)
    < 40 copies/mL (undetectable) 15 (12.9%) Ref. Ref.
    ≥ 40 copies/mL (detectable) 8 (23.5%) 2.1 0.8–5.4 2.1 0.6–7.7
Prevalent Cervical HPV 16
    No 19 (13.2%) Ref. Ref.
    Yes 4 (80.0%) 26.3 2.8–248.1 14.7 1.0–222.5
Anogenital herpes in past 6 months (self-report)
    No or don’t know 18 (13.0%) Ref. Ref.
    Yes 5 (45.5%) 5.6 1.5–20.3 9.8 1.7–56.8
Lifetime number of anal sex partners
    0 or 1 16 (12.0%) Ref. Ref.
    2 or more 7 (41.2%) 5.1 1.7–15.3 3.0 0.7–12.2

Note. HPV, human papillomavirus; CI, confidence interval; OR, odds ratio; Ref., reference category. The dependent variable, anal HPV 16 infection, was coded as 0 = "No HPV type 16 DNA detected in anal canal" and 1 = "HPV type 16 DNA detected in anal canal". The following variables were included in the adjusted model: age as a numerical continuous variable, smoking status, CD4 count at baseline, nadir CD4 count, HIV viral load at baseline, prevalent cervical HPV-16, self-reported history of anogenital herpes in the past 6 months, total of 2 or more partners for recent or remote anal sex.